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Genome Technology Access Center (GTAC)  
By Richard Head
The Genome Technology Access Center (GTAC) is an ICTS associated core facility that offers state-of-the-art ser-
vices in Next Generation Sequencing (NGS), Microarrays (DNA & RNA), PCR, and Bioinformatics.  The GTAC was 
established in 2010 through the WU Department of Genetics to provide access to a wide range of genomic services 
for WU investigators, as well as external collaborators. The center became affiliated with the ICTS in 2011 under 
the ICTS Genomic Medicine Program (GMP) that specifically supports one of the three ICTS renewal cross-cutting 
themes: to translate the findings of genetic/genomic research into clinical research and practice. The GMP offers a 
portal to WU cores providing services related to genomic analysis.
The new technologies offered by GTAC facilitate the discovery of biomarkers and disease signatures and enable the 
highly accurate sequencing of genomes and gene subsets. Core services are customized and tailored to investigators’ 
projects, and GTAC staff members work closely with investigators to design testing that is specific to their project 
goals and specimen types. These services are unique in that they are not available via other campus cores or commer-
cial companies. The core can provide CLIA-quality performance for research prices. 
A significant number of changes have occurred for GTAC within the last year. In October of 2011, Richard Head, 
Research Associate Professor of Genetics, was named the GTAC Director and Mike Heinz the Assistant Director.    
In November, the Microarray and PCR labs moved to their new location in the Cortex building and the bioinformat-
ics group relocated to Cortex in the spring of 2012.  In July, the Siteman Cancer Center’s MGA core, already housed 
within Cortex, became part of GTAC, thus providing access for Siteman members to all GTAC services.  Finally, a 
number of new technologies and protocols were put in place to broaden the services available to the research com-
munity.           Continued: Page 2
ICTS NIH Award Successfully Renewed: The Next 5 Years
As most of you know, our ICTS/CTSA competing renewal application was successful, and we were funded as of June 
2012, through 2017. I would like to extend my sincere thanks to the many people who played important roles in the 
renewal application, including the core directors, the Executive Committee, and many other faculty and staff who were 
essential to our successful renewal. In particular, I would like to thank Becky Evans, Jae Al-
len, and Jaimee Stagner, whose hard work, creativity, and attention to detail were essential to 
the renewal.
The transition of the national CTSA consortium program from NCRR to the newly cre-
ated NIH Institute, NCATS (National Center for Advancing Translational Science), is now 
complete. While it is clear that the CTSA programs will evolve under NCATS, most notably 
through stronger emphases on the development of new therapeutics and on supporting 
multi-institutional studies initiated by other NIH Institutes and Centers, NCATS leaders 
continue to express strong support for the full range of translational research from bench to 
community implementation. 
Renewal Aims
In the next 5 years, the ICTS will continue its 3 major aims: 1) provide access to research support infrastructure and 
other research resources to support multidisciplinary clinical and translational research, 2) expand and enhance clini-
cal and translational research education programs, and 3) promote and facilitate increased communication, interac-
tion, and collaboration within WU and with regional and national partners. In our first 5 years, we pursued these 3 
aims with a broad goal: “to provide outstanding environments and resources for investigators engaged in clinical and 
translational research.”                                                                                                                                      Continued: Page 3  
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Current GTAC Services
	 •			Next Generation Sequencing :  GTAC offers DNA (Targeted, Whole Exome, Whole Genome) and RNA (Poly A Selection,   
      Ribosomal Depletion, Low Input RNA) library preparation and sequencing.  GTAC can prepare libraries or can sequence   
                     libraries made by investigators.
	 •			PCR:  Gene expression, Digital PCR, SNP genotyping, and Amplicon Generation services are all available.  The ABI-7900   
                     and Bio-Rad CFX 96 platforms provide access to traditional PCR services while the new Fluidigm Biomark HD system  
                     provides high throughput and multiplexed capabilities for larger studies in a cost effective manner.
	 •			Microarrays:  Illumina, Agilent, and Affymetrix platforms for DNA and gene expression work are all offered.  For inves-  
                     tigators new to these platforms, GTAC can provide information to assist in making a decision about which platform is  
                     optimal for the proposed study.
	 •			Bioinformatics:  Tier1 bioinformatic services, through the generation of the variant call file (VCF), are provided as part of   
                     the delivery of sequencing data at no extra charge.  Custom bioinformatics support for sequencing and microarray data is   
                     also available on a fee-for-service basis.
	 •			CAP/CLIA Clinical Sequencing, Microarrays, and PCR:  GTAC provides a number of CAP certified CLIA assays in these  
                    areas, however, these services are only available through Genomics and Pathology Services (GPS) at Wash U (http://gps. 
                    wustl.edu/).
Coming Soon to GTAC
	 •			New Web Site:  Coming online October 1st, a redesigned GTAC web site (http://gtac.wustl.edu) will provide information    
                     on all of the major technologies offered and investigators will be able to see how long the sample submission queues are  
                    for each of our research platforms.   
	 •			Online Sample Submission:  In fall 2012, we will convert to an online sample submission form allowing the user to upload  
                     the sample information electronically and simply attach a copy when delivering samples. This will eventually be tied in  
                     with the billing system and with a system to track publications and acknowledgements for investigators who used GTAC  
                     services.
	 •			C1 Single Cell Gene Expression:  GTAC recently purchased a C1 Single-Cell Auto Prep System from Fluidigm.  This sys- 
                     tem simplifies isolation of individual cells for gene expression analysis.  The system is expected to be online in October of  
                     2012.
	 •		 Illumina HiSeq 2500 Upgrades:  In late 2012, the Illumina HiSeq 2000s will be upgraded to 2500s.  The new 2500 systems  
                     will enable one day sequencing for formats such as 2x101 that previously required 11-12 days. 
The GTAC labs are currently located in the Cortex and 4444 Forest Park buildings.  The core staff welcomes inquiries from all inter-





Single Cell Gene Expression System – The Fluidigm C1 and 
BioMark systems provide an integrated platform for doing 
single cell gene expression.  The C1 can capture and harvest 
RNA from up to 250 individual cells.  The C1 product can 
then be assayed (RT-PCR) on the BioMark HD.
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Translation Focus
In the next 5 years, our overall goal will become more focused on the translation of scientific discoveries into improvements in 
human health. ICTS funding and resources will be increasingly directed to projects whose results may lead to improvements in 
prevention, diagnosis, or treatment.  To this end, we have identified 3 cross-cutting scientific themes that will promote interdisci-
plinary interactions across multiple ICTS cores, programs, and research groups where the resources of the ICTS, WU, and ICTS 
partner institutions are most likely to result in high-impact clinical research and its subsequent translation into clinical practice. 
While our ICTS will continue to support and advance clinical and translational science across diverse research areas, these new 
translational science themes address areas of national scientific importance, and take advantage of new and existing strengths in 
clinical and basic science at our institutions. 
Theme 1: Translate the findings of genetic/genomic research into clinical research and practice. WU has tremendous strengths in 
genetic and genomic research, which in several instances has been successfully applied to patient care. An important goal of our 
ICTS is to translate this wealth of discovery into clinically useful tools for prevention, diagnosis, and treatment of human diseases. 
Our plans are consistent with the newly released strategic plan for the NHGRI “Charting a course for genomic medicine from base 
pairs to bedside” [1], which describes a progression from understanding the structure and biology of the genome to understanding 
the biology of disease, advancing the science of medicine, and ultimately improving the effectiveness of health care.
Theme 2: Accelerate the development and evaluation of new therapeutics and diagnostics. Basic science discoveries improve health 
through translation of research findings into new diagnostic, preventive, or therapeutic options, and the successful development 
and appropriate dissemination of new therapeutics is among the highest impact activities in translational science. Crossing the 
“translational divide” separating new discoveries from their rational use as new therapeutics and diagnostics is our second cross-
cutting scientific theme. This theme is consistent with the mission statement of NCATS: “To catalyze the development of innovative 
methods and technologies that will enhance the development, testing, and implementation of diagnostics and therapeutics across a 
wide range of human diseases and conditions.”
Theme 3: Conduct comparative effectiveness and dissemination and implementation research to improve the transfer of clinical 
research discoveries into practice. An important goal of our ICTS is to advance later-stage translational research that evaluates the 
effectiveness of new laboratory tests, diagnostics, imaging modalities, devices, and treatments in real-world settings and speeds 
the adoption of evidence-based best practices into clinical practice in community settings. There is a significant need to perform 
comparative effectiveness research (CER) to better determine what diagnostic methods, treatments, and devices work best in actual 
practice settings. After demonstration of effectiveness in real-world settings, another translational gap looms, as evidence-based 
practices are most often disseminated passively, usually with little uptake. Implementation research comprises studies of processes 
and strategies that move, or integrate, evidence-based effective treatments into routine use in usual care settings. Without better 
understanding and infrastructure to promote dissemination and implementation, “the application of proven solutions in health 
practice will continue to occur slowly and rarely.” [2]
The first 5 years of the ICTS can be seen as a “disruptive innovation”- an innovation that changes social practices and is character-
ized by new products and services offering greater accessibility, appeal to new groups, and improvements in performance along 
novel dimensions (Yes, I’ve been reading some management texts). We now have another 5 years to work together on advancing 
clinical and translational research. Personally, I look forward to working with ICTS members and institutions to sustain what we’ve 
built.   
 1.  Green ED, Guyer MS. Charting a course for genomic medicine from base pairs to bedside. Nature. 2011 Feb 10;470(7333):204-13. PMID: 21307933
 2.  Kreuter MW, Bernhardt JM. Reframing the dissemination challenge: a marketing and distribution perspective. Am J Public Health. 2009 99(12): 
      2123-7. PMID: 19833993 
ICTS has new grant numbers,  
remember to cite the NIH CTSA 
Grant # UL1 TR000448 when your 
research was supported by ICTS/
CTSA funds or services.
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New  KL2 Career Development Scholars
 
The ICTS welcomes 6 new clinical research scholars to the ICTS Center for Clinical Research Training KL2 2012 cohort.  
The KL2 Career Development Awards are aimed at fellows, post-doctoral scholars, and junior faculty who are committed 
to multidisciplinary careers in clinical and translational research.  
 
 
  Yo-El Ju, MD
  Assistant Professor, Department of Neurology, Division of Sleep Medicine
  Washington University School of Medicine
  “Slow Wave Sleep and Amyloid: Linking Synaptic Activity, Apneas, and Alzheimer’s”
  Mentors: David Holtzman and Paul Shaw
 Cynthia Ortinau, MD
 Instructor, Department of Pediatrics, Division of Newborn Medicine 
 Washington University School of Medicine 
 “Cerebral Alterations in Infants with Complex Congenital Heart Disease” 
 Mentors:  Terrie Inder and Pirooz Eghtesady 
 
 Iskra Pusic, MD
  Instructor, Department of Internal Medicine, Division of Medical Oncology     
  Washington University School of Medicine
  “Maintenance Therapy with Decitabine after Allogeneic Stem Cell Transplantation”
  Mentors: John DiPersio and Mario Castro
 
 Cynthia Rogers, MD
 Assistant Professor, Department of Psychiatry, Child and Adolescent Psychiatry 
 Washington University School of Medicine 
 “Assessing Impact of Early Environment on Development of Preterm Infants with MRI” 
 Mentors:  Terri Inder and Joan Luby 
 Michael Seifert, MD
 Assistant Professor, Department of Pediatrics, Division of Pediatric Nephrology 
 Southern Illinois University School of Medicine 
 The Chronic Kidney Disease - Mineral and Bone Disorder in Chronic Allograft Injury” 
 Mentors: Daniel Brennan and Dwight Towler 
  Andrea Wang-Gillam, MD, PhD
  Assistant Professor, Department of Internal Medicine, Division of Oncology 
  Washington University School of Medicine
  “Evaluation of Lapatinib in Pancreatic Cancer Patients With Activated HER1/2”
  Mentors: Lee Ratner and Jason Weber
National CTSA Update
New NCATS Director Named
Christopher P. Austin, MD, was named director of NCATS, effective September 23, 2012. Dr. Austin’s new NCATS role 
was announced by NIH Director Francis S. Collins, M.D., Ph.D., at the inaugural meetings of the NCATS Advisory Council 
and Cures Acceleration Network (CAN) Review Board.  See the NIH Press Release. 
 
Discovering New Therapeutic Uses for Existing Molecules Pilot Program 
NCATS recently launched the Discovering New Therapeutic Uses for Existing Molecules pilot program which will match 
scientists with industry-provided molecular compounds.  Five new industry partners have joined Pfizer, AstraZeneca and 
Eli Lilly in the initiative. See the NIH Press Release. 
Find research resources and keep up with national CTSA news at:  https://www.ctsacentral.org/ 
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2012 ICTS Clinical Research Training Center Pre-Doctoral Students 
The ICTS Clinical Research Training Center (CRTC) supports multiple pre-doctoral research training programs and 
we are pleased to recognize the 2012 trainees in the photos below.  The TL1 program promotes clinical research train-
ing among pre-doctoral students including a short-term summer research program, an intensive one-year research 
program, and a multi-year standard research training program for individuals working toward a PhD.  In addition, 
the Advanced Summer Program for Investigation and Research Education (ASPIRE), was launched in the summer of 
2010 for high school and college students to provide mentored research experiences and didactic training in clinical 
and translational research.  The 2012 summer cohort included 10 high school and 10 college students. The pre- 
doctoral programs are led by Jay Piccirillo, MD, FACS, CPI. 
To learn more about the pre-doctoral programs, visit the CRTC website or contact Jessica Phelan, Program 
Coordinator, at (314) 454-8255 or jphelan@dom.wustl.edu.
First Master of Science in Clinical Research Management Graduates
ASPIRE High School - David Ayeke, Kelley Bell, Ravenna 
Boodram, Varun Chakravarthy, Amy Cui, Edward (Ted) 
Grace, Conor Joplin, Megan Kastner, Meera Zassenhaus, 
and Melissa Zhang
ASPIRE College - Erica Barnell, Kevin Bock, Morgan 
Carlile, Christopher Cartmill, Caitlin Moliske, Taylor Real, 
Allyson Renth, Kristen Shaw, Aravind Somasundaram,  
and Tanvi Subramanian
New TL1 2012 Intensive and Stamdard Trainees include: Ryan Bailey,  Meg Feely, 









The Clinical Research Management Graduate Program conferred the first Master of Science degrees to 6 students on May 16, 
2012.  The graduates are Sally Anderson, Stephanie Belyew, Chad Hampton, Erin Householder, Amy Reeves, and Alexandra 
Timpson. The Master of Science in Clinical Research Management is designed for experienced professionals working in academic 
research centers or private industry who seek greater depth and breadth of study in the science and business of clinical research 
and is awarded by University College, the evening and continuing education division of Washington University Arts & Sciences.
For more information on the Clinical Research Management Program (BS, MS, Undergraduate/Graduate Certificate), contact 
Sally Anderson, Manager of the Clinical Trials Core (CTC) Education Program, (314) 747-4126 or anderson@siteman.wustl. edu.
TL1
Trainees
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Research Navigator
Inquiries directed to the ICTS Research Navigator, via e-mail or 
phone, are currently being monitored by the ICTS Administrative 
Core staff and triaged to the appropriate expert.  
To learn about services, visit the ICTS Cores and Resources website 
or contact the ICTS at 314-362-9829 or ICTSNavigator@wustl.edu 
for assistance.
 
Attention ICTS LINC Members:
The next LINC meeting will take place from 12:00 to 1:00pm in 
BJCIH Room 10A/B on October 26.  Hope to see you there!
Upcoming Events
ICTS Brown Bag Seminars 
 
October 24 (Noon-1:00p.m.) 
Center for Administrative Data Research (CADR)
Margie Olsen, PhD 
 
November 27 (Noon-1:00p.m.) 
Washington University Patient Safety 
Mary Taylor, Director,  WU Patient Safety 
 
ICTS Brown Bag 2 Seminars for Behavioral Research
November 14 (Noon-1:00p.m.) 
TBD  
 
Holden Auditorium, Farrell Learning & Teaching Center, WU Medical 
Center Campus.  Register via HRMS Self Service,  Training &  
Development.  Non-WU staff email ICTS@wustl.edu.  
HRPO SWAT!
Did you know the WU Human Research Protection Office (HRPO) 
has 2 programs designed to get you quick answers?  Be sure to take 
advantage of these options available through the HRPO SWAT! (Staff 
With Answers Today) Program: 
HRPO SWAT! On Call: 
				•		Call	HRPO	at	633-7400	from	8-4	every	day	and	get	immediate			
        assistance by asking for the on-call staff member. 
				•		Chat	with	HRPO	staff	directly	through	myIRB.	Click	the	“chat”		
        icon next to your name in the upper right hand corner of my    
        IRB. 
HRPO SWAT! Office Hours: 
				•		HRPO	reviewers/analysts	available	in	person	throughout	the						
        week.
				•		Computers	available	to	work	through	an	application	with	you		
        on the spot. 
Danforth Campus - Monday and Thursday from 1-4 in Psych 202 




Do you know what PMCID means?  Are you familiar with the 
NIH Public Access policy?  Do you realize that authors will 
NOT be allowed to list publications on NIH grant applications 
or progress reports if those publications are not in compliance 
with this policy?
Simply stated, if your research is funded through NIH, you 
are legally required to get a PMCID within three months of 
publication.
Don’t know how to get a PMCID?  The Becker Medical Library 
website has excellent resources, both on their website and an 
expert on staff, namely Cathy Sarli (sarlic@wustl.edu).  If you 
aren’t already familiar with and following this policy, ask for 
help now!
NIH Public Access Policy Brown Bag Presentation 
Wednesday, November 14, 2012 
12:00pm - 1:00pm 
Farrell Learning and Teaching Center, Room 213 
Registration Link or email Cathy Sarli
 
  7th Annual Research Symposium and Poster Session
 
                                       October 31, 2012
                                        12:30pm – 5:00pm 
      Connor Auditorium, Farrell Learning and Teaching Center
                                     WU Medical Center Campus
 
                   Keynote  Speaker - Curtis Lowery, Jr., MD
         Chairman and Professor, Department of Obstetrics and 
        Gynecology; CTSA Director 
              The University of Arkansas for Medical Sciences
 
      No registration required.  For more information contact 
      Joe Wilson, CRTC Media and Events Coordinator 
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WU Institute for Public Health Annual Conference
 
“Rising to the Challenge: Public Health in the  
21st Century”
 
October 9, 2012 
12:30pm - 5:00pm 
Eric P. Newman Education Center,  
WU Medical CenterCampus 
 
Keynote Address - James S. Marks, MD
Senior Vice President and Director 
Robert Wood Johnson Foundation Health Group 
        Access the registration link or see the IPH website for more 
        information. 
